Brown Advisory
EW icon

Brown Advisory’s Edwards Lifesciences EW Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$572M Sell
7,312,494
-861,339
-11% -$67.4M 0.75% 37
2025
Q1
$592M Buy
8,173,833
+18,478
+0.2% +$1.34M 0.85% 31
2024
Q4
$604M Buy
8,155,355
+575,699
+8% +$42.6M 0.77% 30
2024
Q3
$500M Sell
7,579,656
-8,972,491
-54% -$592M 0.63% 45
2024
Q2
$1.53B Sell
16,552,147
-83,999
-0.5% -$7.76M 2% 8
2024
Q1
$1.59B Sell
16,636,146
-1,545,274
-8% -$148M 2.13% 7
2023
Q4
$1.39B Buy
18,181,420
+3,048,274
+20% +$232M 1.95% 10
2023
Q3
$1.05B Buy
15,133,146
+818,849
+6% +$56.7M 1.72% 12
2023
Q2
$1.35B Buy
14,314,297
+225,931
+2% +$21.3M 2.11% 8
2023
Q1
$1.17B Sell
14,088,366
-252,736
-2% -$20.9M 1.97% 8
2022
Q4
$1.07B Buy
14,341,102
+115,268
+0.8% +$8.6M 1.99% 6
2022
Q3
$1.18B Buy
14,225,834
+423,457
+3% +$35M 2.29% 4
2022
Q2
$1.31B Sell
13,802,377
-1,176,673
-8% -$112M 2.47% 5
2022
Q1
$1.76B Sell
14,979,050
-1,743,248
-10% -$205M 2.63% 4
2021
Q4
$2.17B Buy
16,722,298
+2,548,909
+18% +$330M 2.68% 4
2021
Q3
$1.6B Sell
14,173,389
-17,662
-0.1% -$2M 2.37% 5
2021
Q2
$1.47B Buy
14,191,051
+131,575
+0.9% +$13.6M 2.22% 6
2021
Q1
$1.18B Buy
14,059,476
+478,113
+4% +$40M 2.01% 6
2020
Q4
$1.24B Buy
13,581,363
+895,789
+7% +$81.7M 2.2% 7
2020
Q3
$1.01B Buy
12,685,574
+1,051,269
+9% +$83.9M 2.09% 9
2020
Q2
$804M Buy
11,634,305
+7,925,587
+214% +$548M 1.87% 10
2020
Q1
$700M Buy
3,708,718
+345,799
+10% +$65.2M 2.14% 6
2019
Q4
$785M Sell
3,362,919
-201,427
-6% -$47M 1.99% 5
2019
Q3
$784M Sell
3,564,346
-63,263
-2% -$13.9M 2.2% 4
2019
Q2
$670M Sell
3,627,609
-37,204
-1% -$6.87M 1.92% 5
2019
Q1
$701M Sell
3,664,813
-46,148
-1% -$8.83M 1.99% 5
2018
Q4
$568M Sell
3,710,961
-239,410
-6% -$36.7M 1.91% 6
2018
Q3
$688M Buy
3,950,371
+84,355
+2% +$14.7M 1.96% 5
2018
Q2
$563M Buy
3,866,016
+211,258
+6% +$30.8M 1.73% 10
2018
Q1
$510M Sell
3,654,758
-99,760
-3% -$13.9M 1.65% 13
2017
Q4
$423M Sell
3,754,518
-31,787
-0.8% -$3.58M 1.34% 18
2017
Q3
$414M Sell
3,786,305
-980,428
-21% -$107M 1.37% 16
2017
Q2
$564M Buy
4,766,733
+336,729
+8% +$39.8M 1.72% 7
2017
Q1
$417M Buy
4,430,004
+2,426,413
+121% +$228M 1.42% 15
2016
Q4
$188M Buy
2,003,591
+377,526
+23% +$35.4M 0.67% 40
2016
Q3
$196M Sell
1,626,065
-21,272
-1% -$2.56M 0.67% 39
2016
Q2
$164M Sell
1,647,337
-98,265
-6% -$9.8M 0.58% 46
2016
Q1
$154M Sell
1,745,602
-8,622
-0.5% -$761K 0.53% 45
2015
Q4
$139M Buy
1,754,224
+880,757
+101% +$69.6M 0.47% 48
2015
Q3
$124M Buy
873,467
+22,670
+3% +$3.22M 0.44% 51
2015
Q2
$121M Buy
850,797
+18,741
+2% +$2.67M 0.39% 53
2015
Q1
$119M Sell
832,056
-42,591
-5% -$6.07M 0.38% 53
2014
Q4
$111M Sell
874,647
-269,863
-24% -$34.4M 0.35% 56
2014
Q3
$117M Buy
1,144,510
+157,210
+16% +$16.1M 0.38% 49
2014
Q2
$84.7M Buy
987,300
+2,540
+0.3% +$218K 0.27% 54
2014
Q1
$73M Buy
984,760
+11,343
+1% +$841K 0.23% 61
2013
Q4
$64M Buy
973,417
+773,444
+387% +$50.9M 0.21% 69
2013
Q3
$13.9M Sell
199,973
-16,270
-8% -$1.13M 0.05% 203
2013
Q2
$14.5M Buy
+216,243
New +$14.5M 0.06% 183